<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">JCDSA</journal-id><journal-title-group><journal-title>Journal of Cosmetics, Dermatological Sciences and Applications</journal-title></journal-title-group><issn pub-type="epub">2161-4105</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/jcdsa.2024.141001</article-id><article-id pub-id-type="publisher-id">JCDSA-131269</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  The Effect of a Novel Complex, Composed of Ceramide, Energizing Peptide and Camu Camu Extract, on Epidermal Barrier Function and Dermal Antiaging Properties in &lt;i&gt;Ex Vivo&lt;/i&gt; Human Skin Small Live Cohort
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Landau</surname><given-names>Marina</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Landau-Blum</surname><given-names>Shir</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Samuel</surname><given-names>Kassirer</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Audrey</surname><given-names>Le Mestr</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Armelle</surname><given-names>Perrin</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Julien</surname><given-names>Verdon</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Laurine</surname><given-names>Bergeron</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Corinne</surname><given-names>Morel</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Isabelle</surname><given-names>Imbert</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib></contrib-group><aff id="aff2"><addr-line>American Medical Program, Tel Aviv University, Tel Aviv-Yafo, Israel</addr-line></aff><aff id="aff3"><addr-line>Ashland, Ashland Specialty Ingredients, Sophia Antipolis, France</addr-line></aff><aff id="aff1"><addr-line>Arena Dermatology, Herzliya, Israel</addr-line></aff><pub-date pub-type="epub"><day>21</day><month>02</month><year>2024</year></pub-date><volume>14</volume><issue>01</issue><fpage>1</fpage><lpage>11</lpage><history><date date-type="received"><day>15,</day>	<month>November</month>	<year>2023</year></date><date date-type="rev-recd"><day>19,</day>	<month>February</month>	<year>2024</year>	</date><date date-type="accepted"><day>22,</day>	<month>February</month>	<year>2024</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
   The skin’s primary function is to protect the body against a spectrum of environmental stressors, including mechanical insults, microorganisms, chemicals, and allergens. Located in the outermost layers, the primary structures and components responsible for the skin’s barrier function are susceptible to environmental variables, dermatological conditions, and the aging process. The ensuing alterations to structure, composition, and organizational attributes of the epidermal barrier can impact its integrity and functionality. The aim of this study was to assess the effect of a novel complex composed of a ceramide, energizing peptide, and Camu Camu extract (SUPCERAT<sup>TM</sup> complex) on specific markers of epidermal barrier integrity, as well as epidermal and dermal function. All the experiments were conducted on fresh human abdominal skin explants. Intradermal production of hyaluronic acid, epidermal claudin-1, and ceramide synthase 3 expressions, as well as epidermal lipids content were assessed using specific fluorescent stainings on ex vivo skin after the application of the complex or placebo. Additionally, dermal elastase and collagenase activities were assessed using in tubo enzymatic assays. Lastly, the effect of a cosmetic cream containing SUPCERAT<sup>TM</sup> complex was assessed using subjective Global Aesthetic Improvement Scale (GAIS) in a small cohort of patients after 60 days of use. The application of the SUPCERAT<sup>TM</sup> complex on ex vivo skin led to significant increase in dermal hyaluronic acid content and epidermal activity of claudin-1, ceramide synthase 3 and epidermal ceramide content. Furthermore, in tubo enzymatic assays demonstrated inhibition of both dermal elastase and collagenase activities. In addition, the patient-reported results indicated significant improvements in skin quality and appearance. 
 
</p></abstract><kwd-group><kwd>SUPCERATTM Complex</kwd><kwd> Epidermal Skin Barrier</kwd><kwd> Moisturization</kwd><kwd> Antiaging</kwd><kwd> Ceramide</kwd><kwd> Camu Camu Extract</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Human skin acts as a primary barrier between the body and its environment. It is composed of three main layers: the epidermis, the dermis, and the underlying subcutaneous fat tissue. Each layer differs significantly in terms of composition and function [<xref ref-type="bibr" rid="scirp.131269-ref1">1</xref>] .</p><p>In the epidermis, keratinocytes differentiate and progress from the basal layer to the uppermost layers, undergoing an intricate differentiation process that culminates with the transformation into corneocytes and the formation of the stratum corneum (SC) [<xref ref-type="bibr" rid="scirp.131269-ref2">2</xref>] . Protein members of the epidermal differentiation complex (EDC) are responsible of the terminal differentiation program of the keratinocytes. These include involucrin, loricrin and small proline-rich proteins, responsible for the cornified envelope of the skin and also a number of calcium binding proteins including intermediate-filament associated profilaggrin and trichohyalin, and several S100A proteins [<xref ref-type="bibr" rid="scirp.131269-ref3">3</xref>] . The SC barrier protects against environmental challenges such as physical and chemical insults, UV radiation, and environmental pollution [<xref ref-type="bibr" rid="scirp.131269-ref4">4</xref>] . Additionally, it regulates and limits the loss of fluids and electrolytes [<xref ref-type="bibr" rid="scirp.131269-ref5">5</xref>] . In its compositional profile, the SC is a complex matrix comprising predominantly proteins (75% - 80%) and lipids (5% - 15%) [<xref ref-type="bibr" rid="scirp.131269-ref6">6</xref>] . It is made up of protein-enriched enucleated corneocytes surrounded by a complex extracellular lipid matrix dominated by lipids, mostly ceramides, acylceramides, cholesterol, cholesterol esters, and non-esterified fatty acids (NEFA, commonly referred to as free fatty acids) [<xref ref-type="bibr" rid="scirp.131269-ref2">2</xref>] [<xref ref-type="bibr" rid="scirp.131269-ref7">7</xref>] . Ceramides, integral to this lipid environment, consist of a hydrophobic fatty acid chain linked to an amino containing sphingoid base by a ceramide synthase (CerS) [<xref ref-type="bibr" rid="scirp.131269-ref8">8</xref>] . Of notable significance, CerS3 is highly concentrated in the skin, particularly during keratinocyte differentiation. Granular keratinocytes secrete ceramides via lamellar bodies, contributing to the intercellular matrix of the SC and providing an effective barrier that impedes the passage of water [<xref ref-type="bibr" rid="scirp.131269-ref9">9</xref>] . The integrity of the skin barrier is also dependent on the tight junctions (TJ) that seal the intercellular spaces between adjacent keratinocytes in the stratum granulosum, found below the SC [<xref ref-type="bibr" rid="scirp.131269-ref2">2</xref>] . The “tightness” of this structure determines the trafficking patterns of ions, proteins and even the penetration of the dendrites of Langerhans or dendritic cells [<xref ref-type="bibr" rid="scirp.131269-ref10">10</xref>] [<xref ref-type="bibr" rid="scirp.131269-ref11">11</xref>] . Notably, the transmembrane protein claudin-1 assumes a pivotal role within TJ; its depletion beyond a critical threshold results in impairment of both TJ and epidermal barrier function, leading to subsequent inflammation in the human epidermis [<xref ref-type="bibr" rid="scirp.131269-ref12">12</xref>] .</p><p>The dermis, which underlies and is connected to the epidermis at the basement membrane level, imparts elasticity and strength to the skin through the synthesis of two major extracellular matrix (ECM) proteins: elastin and collagen [<xref ref-type="bibr" rid="scirp.131269-ref13">13</xref>] . During the aging process, mitochondrial dysfunction, associated with excessive production of reactive oxygen species (ROS), induces a cascade of transcription factor activation that culminates in the over-expression of matrix metalloproteinases (MMPs). MMPs 1, 3 and 9 play a significant role in the degradation of the dermal ECM. Specifically, collagen undergoes an initial cleavage by MMP 1, followed by complete degradation facilitated by MMPs 3 and 9. Additionally, MMP 9 is capable of degrading elastic fibers [<xref ref-type="bibr" rid="scirp.131269-ref14">14</xref>] [<xref ref-type="bibr" rid="scirp.131269-ref15">15</xref>] . Diminished levels of these functional dermal components precipitate clinically observable features, including the development of wrinkles and reduced skin elasticity [<xref ref-type="bibr" rid="scirp.131269-ref16">16</xref>] .</p><p>Furthermore, the content of hyaluronic acid (HA) in both the epidermis and the dermis serves as a reliable indicator of hydration. HA, a high molecular weight glycosaminoglycan, stands as the predominant component of the skin extracellular matrix, with water-binding and electrolyte control properties. The hydration status of the skin critically depends on the water tightly bound by HA within both the dermal and epidermal layers [<xref ref-type="bibr" rid="scirp.131269-ref17">17</xref>] [<xref ref-type="bibr" rid="scirp.131269-ref18">18</xref>] .</p><p>The hypodermis is deep to the dermis and is also called subcutaneous fascia. It is the deepest layer of skin and contains adipose lobules along with some skin appendages like the hair follicles, sensory neurons, and blood vessels [<xref ref-type="bibr" rid="scirp.131269-ref1">1</xref>] .</p><p>In accordance with these data, we investigated the efficacy of SUPCERAT<sup>TM</sup> complex comprising three active ingredients: ceramide, Camu Camu superfruit extract and an energizing peptide.</p><p>Ceramides, extracted from a rice extract utilizing a process designed to optimize the sphingolipids and phospholipids fraction, was previously described as a booster of skin hydration. Camu camu, acknowledged as a “superfruit,” is distinguished for its superior vitamin C content. Vitamin C is naturally present in skin dermis and epidermis, and it acts as a potent antioxidant that can neutralize and remove oxidants, such as those found in environmental pollutants and after exposure to ultraviolet radiation. Besides, it acts as a co-factor for the proline and lysine hydroxylases that stabilize the collagen molecule tertiary structure, and it also promotes collagen gene expression. Vitamin C level is lower in aged or photodamaged skin [<xref ref-type="bibr" rid="scirp.131269-ref19">19</xref>] [<xref ref-type="bibr" rid="scirp.131269-ref20">20</xref>] . Furthermore, the energizing peptide was designed to enhance cell energy rebound. Its application on in vitro cells resulted in an increase in ATP cellular levels and triggered intracellular calcium flashes (data not shown), subsequently boosting fundamental physiological processes.</p><p>New insights of SUPCERAT™ efficacy were garnered concerning skin barrier by evaluating claudin-1 expression, epidermal lipids by Nile Red staining and CerS3 expression on ex vivo skin biopsies. Skin hydration was studied through HA level on ex vivo skin. Complementary in tubo enzymatic assays were employed to assess collagenase and elastase inhibition properties. Finally, clinical testing conducted on human volunteers demonstrated a global healthy-looking skin.</p></sec><sec id="s2"><title>2. Materials and Methods</title><p>Skin culture</p><p>Normal human skin, obtained from abdominal plastic surgery of a 39-year-old female donor, was utilized for this study. Skin biopsies were obtained with a 6 mm diameter punch (pfm medical, Cologne, Germany) and maintained in organotypic culture with 50% of Dulbecco’s modified Eagle’s medium (DMEM) 1 g∙L<sup>−1</sup> glucose (Lonza, Bazel, Switzerland) and 50% of Ham’s-F12 (Lonza) medium supplemented with 10% of fetal bovine serum (Lonza), 2 mM L-Glutamine (Lonza) and 100 &#181;g∙mL<sup>−1</sup> Primocin™ (InvivoGen, San Diego, CA, U.S.A.). The skin biopsies were maintained at 37˚C and 5% CO<sub>2</sub> in a humidified atmosphere.</p><p>A 20 &#181;l volume of the SUPCERAT<sup>TM</sup> complex was applied to the top of the biopsies, twice a day for 24 hours or 48 hours. Phosphate Buffer Saline (PBS) served as the control.</p><p>Chemicals and antibodies</p><p>Several antibodies were used for these studies. The primary antibodies utilized included rabbit anti-ceramide synthase 3, diluted at 1/200 (Bio-Techne, Minneapolis, U.S.A.), and rabbit anti-claudin 1, diluted at 1/200 (Abcam, Cambridge, UK). The secondary antibodies consisted of donkey anti-rabbit or streptavidin, conjugated to Alexa Fluor<sup>&#174;</sup> 488, and were diluted at 1/1000 (Molecular Probes, Thermo Fisher Scientific).</p><p>HA was stained using biotinylated anti-hyaluronic acid binding protein, diluted at 1/400 (Sigma-Aldrich, MO, U.S.A.).</p><p>Epidermal lipids were stained using Nile red (Sigma-Aldrich). A stock solution containing 0.05% (wt/vol) Nile red in acetone was stored at 4˚C, protected from light. Prior to each staining, the stock solution was diluted to 100 &#181;M with acetone and further diluted to 100 nM with PBS.</p><p>Biopsy preparation</p><p>To facilitate preservation and further skin sectioning, tissues were fixed for 4 hours in 10% buffered formalin. Subsequently, samples underwent a series of treatments: immersion in baths with increasing concentrations of ethanol to remove water, followed by transfer to two baths of xylene to eliminate the alcohol. Finally, the samples were embedded in molten paraffin wax. The embedded skin biopsies were then sliced into 4 &#181;m thick sections using a microtome (Shandon) and placed on glass slides.</p><p>Immunofluorescent stainings on paraffin-embedded ex vivo skin</p><p>Paraffin-embedded sections of 4 &#181;m thickness were dewaxed in xylene and rehydrated through a graded series of ethanol and water applications, as per routine histology protocol. The sections were then washed in PBS, and antigen retrieval was achieved through enzyme digestion and/or microwave exposure in citrate buffer (0.01 M, pH 6). After blocking non-specific sites with 5% Bovine Serum Albumin (BSA) (Sigma-Aldrich) for 30 minutes, the sections were incubated with a primary antibody. Following washing with PBS, a secondary antibody was applied. Finally, after further washing, the slides were mounted with Fluoromount-G<sup>&#174;</sup> containing DAPI for blue nuclei staining (Electron Microscopy Sciences, Hatfield, PA, U.S.A.).</p><p>Nile red staining</p><p>Paraffin-embedded sections, measuring 4 &#181;m in thickness, underwent dewaxing in xylene and subsequent rehydration through a graded series of ethanol and water applications, as per routine histology protocol. The sections were washed in PBS, and 100 nM Nile red solution was applied for 10 minutes. Finally, after washing, the slides were mounted with Fluoromount-G<sup>&#174;</sup> avec DAPI (Electron Microscopy Sciences).</p><p>Fluorescence microscopy</p><p>Tissue sections were examined by fluorescence microscopy using a Nikon Eclipse 80i microscope (Nikon, Champigny sur Marne, France) with a 20x objective. Photomicrographs were taken with a Nikon Digital Camera DMX1200F (Nikon) and captured using Q-Capture Pro 7™ acquisition software (QImaging<sup>&#174;</sup>, Canada).</p><p>Image quantification methodology</p><p>Five images per condition were analyzed with Volocity<sup>&#174;</sup>. This software quantifies the luminosity of each pixel, and all the values obtained were added. The resultant luminosity values were normalized to the area of the examined zone of each photograph. Statistical significance was assessed using a one-tailed unpaired Student’s t-test with p &lt; 0.05 considered significant, p &lt; 0.01 very significant, and p &lt; 0.005 highly significant.</p><p>Collagenase inhibitory assay</p><p>The employed assay was based on fluorescent spectrophotometric methods. The complex was incubated with the assay system following manufacturer’s instructions (E12055, EnzChek™ Gelatinase/Collagenase Assay Kit; Thermo Fisher Scientific, Inc., Waltham, MA, USA) with some modifications tailored for use in microplate reader use. The assay was initiated by adding collagenase (type IV from Clostridium histolyticum), reaction buffer, and the complex to each well, with a final enzyme concentration of 0.2 units/ml. The complex was incubated with the enzyme and reaction buffer for 25 minutes at room temperature. Following incubation, the substrate of the enzyme, DQ™ gelatin, was added to start the reaction. The fluorescence of the digested product of the DQ™ gelatin was measured immediately after adding substrate and then continuously monitored for 30 minutes at 495 nm absorbance using a microplate spectrophotometer (Bio Tek Synergy 2). Gallic acid at 0.1% served as a positive control for the inhibitory effect. Negative controls were conducted by replacing the complex with reaction buffer.</p><p>Elastase inhibitory assay</p><p>The assay employed utilized fluorescent spectrophotometric methods. The complex was incubated with the assay system following manufacturer’s instructions (E12056, EnzChek™ Elastase Assay Kit; Thermo Fisher Scientific, Inc., Waltham, MA, USA) with some modifications for microplate reader applications. The assay was initiated by adding elastase (derived from pig pancreas), reaction buffer, and the complex to each assay well, with a final enzyme concentration of 0.1 units/ml. The complex was incubated with the enzyme and reaction buffer for 25 minutes at room temperature. Following incubation, the substrate of the enzyme, the DQ™ elastin, was added to start the reaction. The fluorescence of the digested product of the DQ™ elastin was measured immediately after adding substrate and continuously monitored for 30 minutes at 485 nm absorbance using a microplate spectrophotometer (Bio Tek Synergy 2). Gallic acid at 0.1% served as a positive control for the inhibitory effect. Negative controls were performed by replacing the complex by reaction buffer.</p><p>Clinical study</p><p>Ten female participants, with ages ranging from 28 to 70, were enrolled in the study. Instructions were provided directing them to abstain from the use of any cosmetic product, except for moisturizing cream containing 5% SUPCERAT<sup>TM</sup> complex, applied twice daily over the span of 60 days. Following the intervention period, participants were questioned regarding the perceived changes in their skin quality, with the following response options: their skin quality became worse, no change, improved, much improved, or very much improved.</p></sec><sec id="s3"><title>3. Results</title><p>Elastase and collagenase inhibition properties of the complex</p><p>The intrinsic properties of the complex to inhibit elastase and collagenase activities were assessed through in tubo enzymatic studies. Results showed a strong inhibition of the collagenase activity by 93% and elastase activity by 36%. Comparable effects were observed with the positive control, gallic acid, administered at 1 mg/mL (<xref ref-type="fig" rid="fig1">Figure 1</xref>).</p><p>Effect of the complex on skin barrier integrity and moisturization</p><p>The complex was applied twice a day over a 24-hour period on human ex vivo skin, and its direct impact on skin barrier integrity was assessed through the immuno-histochemical analysis of claudin-1 and CerS3. An increase of 37%*** and 55%***, respectively, in staining intensity was observed in the treated condition compared to the control. Furthermore, Nile red staining revealed a higher content in epidermal lipids by 185%*** after a 48-hour application of the complex, in comparison to the control condition (<xref ref-type="fig" rid="fig2">Figure 2</xref>).</p><p>Similarly, the effect of the complex on skin moisturization was highlighted by an enhancement of hyaluronic acid production (64%***) observed in the treated samples (<xref ref-type="fig" rid="fig3">Figure 3</xref>) after 24 hours of application, as compared to the control.</p><p>Clinical evaluation</p><p>Lastly, the effects of the SUPCERAT<sup>TM</sup> complex, integrated into a formulated product, were evaluated on human volunteers. Out of the 10 participants surveyed regarding their perception of skin quality, 5 reported a very significant improvement, 3 reported significant improvement, and one participant noted an improvement in skin quality (<xref ref-type="table" rid="table1">Table 1</xref> and <xref ref-type="fig" rid="fig4">Figure 4</xref>).</p></sec><sec id="s4"><title>4. Discussion &amp; Conclusions</title><p>In the present study, we assessed the efficacy of a complex comprising ceramides, an energizing peptide, and a camu camu extract on parameters reflecting dermal aging, epidermal barrier integrity, and hydration, ultimately aiming to enhance the overall appearance of the skin. In tubo evaluations revealed that the SUPCERAT<sup>TM</sup> complex inhibited collagenase and elastase activities, comparable to gallic acid, which served as a positive control in this study. Elastin and collagen, key components of the dermal ECM, have a pivotal role in skin strength</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Global aesthetic improvement scale assessment (GAIS)</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Subject</th><th align="center" valign="middle" >1</th><th align="center" valign="middle" >2</th><th align="center" valign="middle" >3</th><th align="center" valign="middle" >4</th><th align="center" valign="middle" >5</th><th align="center" valign="middle" >6</th><th align="center" valign="middle" >7</th><th align="center" valign="middle" >8</th><th align="center" valign="middle" >9</th><th align="center" valign="middle" >10</th><th align="center" valign="middle" ></th></tr></thead><tr><td align="center" valign="middle" >Very much improved</td><td align="center" valign="middle" >X</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >X</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >X</td><td align="center" valign="middle" >X</td><td align="center" valign="middle" >40%</td></tr><tr><td align="center" valign="middle" >Much improved</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >X</td><td align="center" valign="middle" >X</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >X</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >30%</td></tr><tr><td align="center" valign="middle" >Improved</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >X</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >X</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >20%</td></tr><tr><td align="center" valign="middle" >No change</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >X</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >10%</td></tr><tr><td align="center" valign="middle" >Worse</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >0%</td></tr></tbody></table></table-wrap><p>and the elasticity. It is noteworthy that camu camu extract, previously shown to exhibit antioxidant and mitochondrial protection properties, demonstrated potential in preventing ROS-induced expression of MMPs, thereby protecting elastin and collagen fibers from degradation [<xref ref-type="bibr" rid="scirp.131269-ref21">21</xref>] . Moreover, experiments on ex vivo skin highlighted the complex’s ability to preserve the epidermal barrier function by acting on the 2 major barrier structures: the SC, the outmost layer, and the TJs, intercellular junctions that seal adjacent keratinocytes in the stratum granulosum, found below the SC. Indeed, an increased expression of the major TJs protein claudin-1 was observed after the application of the complex. Tight junctions act as a semipermeable barrier to the paracellular transport of ions, solutes and water, as well as cells, and are considered to function as a fence that divides apical and basolateral domains of plasma membranes [<xref ref-type="bibr" rid="scirp.131269-ref22">22</xref>] . In addition, an elevated level of epidermal lipids associated with an increase of CerS3 expression showed after the application of the complex emphasized the potential of SUPCERAT™ to reinforce the extracellular lipid matrix of the SC. CerS3 has been determine as essential for the synthesis of cornified lipid envelope and extracellular lipid and importantly for Ceramide-derived sphingosines. Hence, CerS3 determines the quality of the water permeability barrier and antimicrobial function as well as final cornification [<xref ref-type="bibr" rid="scirp.131269-ref23">23</xref>] . This result is also aligning with the composition of the complex that includes a ceramides fraction. Finally, the increased expression of HA in ex vivo skin suggested a potential enhancement in moisturization capacity induced by the complex [<xref ref-type="bibr" rid="scirp.131269-ref17">17</xref>] [<xref ref-type="bibr" rid="scirp.131269-ref18">18</xref>] . When SUPCERAT<sup>TM</sup> complex was integrated into a cosmetic cream and used by patients, all participants reported an improvement/significant improvement/very significant improvement in their skin quality and appearance after 60 days of twice-daily use.</p><p>In conclusion, this study demonstrates the positive effects of a newly developed complex on both epidermal barrier integrity and function, showcasing anti-aging potential in human skin explants and an enhancement in skin quality for real patients.</p></sec><sec id="s5"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest regarding the publication of this paper.</p></sec><sec id="s6"><title>Cite this paper</title><p>Marina, L., Shir, L.-B., Kassirer, S., Le Mestr, A., Perrin, A., Verdon, J., Bergeron, L., Morel, C. and Imbert, I. (2024) The Effect of a Novel Complex, Composed of Ceramide, Energizing Peptide and Camu Camu Extract, on Epidermal Barrier Function and Dermal Antiaging Properties in Ex Vivo Human Skin Small Live Cohort. Journal of Cosmetics, Dermatological Sciences and Applications, 14, 1-11. https://doi.org/10.4236/jcdsa.2024.141001</p></sec></body><back><ref-list><title>References</title><ref id="scirp.131269-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Yousef, H., Alhajj, M. and Sharma, S. (2022) Anatomy, Skin (Integument), Epidermis. StatPearls Publishing, Treasure Island.</mixed-citation></ref><ref id="scirp.131269-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Brandner, J.M., Zorn-Kruppa, M., Yoshida, T., Moll, I., Beck, L.A. and De Benedetto, A. (2015) Epidermal Tight Junctions in Health and Disease. Tissue Barriers, 3, e974451. https://doi.org/10.4161/21688370.2014.974451</mixed-citation></ref><ref id="scirp.131269-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Abhishek, S. and Palamadai, K.S. (2016) Epidermal Differentiation Complex: A Review on Its Epigenetic Regulation and Potential Drug Targets. Cell Journal, 18, 1-6.</mixed-citation></ref><ref id="scirp.131269-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Parrado, C., Mercado-Saenz, S., Perez-Davo, A., Gilaberte, Y., Gonzalez, S. and Juarranz, A. (2019) Environmental Stressors on Skin Aging. Mechanistic Insights. Frontiers in Pharmacology, 10, Article No. 759. https://doi.org/10.3389/fphar.2019.00759</mixed-citation></ref><ref id="scirp.131269-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Rawlings and Harding (2004) Moisturization and Skin Barrier Function. Dermatologic Therapy, 17, 43-48. https://doi.org/10.1111/j.1396-0296.2004.04S1005.x</mixed-citation></ref><ref id="scirp.131269-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Sahle, F.F., Gebre-Mariam, T., Dobner, B., Wohlrab, J. and Neubert, R.H.H. (2015) Skin Diseases Associated with the Depletion of Stratum Corneum Lipids and Stratum Corneum Lipid Substitution Therapy. Skin Pharmacology and Physiology, 28, 42-55. https://doi.org/10.1159/000360009</mixed-citation></ref><ref id="scirp.131269-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Boncheva, M. (2014) The Physical Chemistry of the Stratum Corneum Lipids. International Journal of Cosmetic Science, 36, 505-515. https://doi.org/10.1111/ics.12162</mixed-citation></ref><ref id="scirp.131269-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Knox, S. and O’Boyle, N.M. (2021) Skin Lipids in Health and Disease: A Review. Chemistry and Physics of Lipids, 236, Article ID: 105055. https://doi.org/10.1016/j.chemphyslip.2021.105055</mixed-citation></ref><ref id="scirp.131269-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Cha, H.J., He, C., Zhao, H., Dong, Y., An, I.S. and An, S. (2016) Intercellular and Intracellular Functions of Ceramides and Their Metabolites in Skin. International Journal of Molecular Medicine, 38, 16-22. https://doi.org/10.3892/ijmm.2016.2600</mixed-citation></ref><ref id="scirp.131269-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Anderson, J.M. and Van Itallie, C.M. (2009) Physiology and Function of the Tight Junction. Cold Spring Harbor Perspectives in Biology, 1, a002584. https://doi.org/10.1101/cshperspect.a002584</mixed-citation></ref><ref id="scirp.131269-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Kubo, A., Nagao, K., Yokouchi, M., Sasaki, H. and Amagai, M. (2009) External Antigen Uptake by Langerhans Cells with Reorganization of Epidermal Tight Junction Barriers. Journal of Experimental Medicine, 206, 2937-2946. https://doi.org/10.1084/jem.20091527</mixed-citation></ref><ref id="scirp.131269-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Bergmann, S., von Buenau, B., Vidal-y-Sy, S., Haftek, M., Wladykowski, E., Houdek, P., Lezius, S., Duplan, H., B&amp;#228;sler, K., D&amp;#228;hnhardt-Pfeifer, S., Gorzelanny, C., Schneider, S.W., Rodriguez, E., St&amp;#246;lzl, D., Weidinger, S. and Brandner, J.M. (2020) Claudin-1 Decrease Impacts Epidermal Barrier Function in Atopic Dermatitis Lesions Dose Dependently. Scientific Report, 10, Article No. 2024. https://doi.org/10.1038/s41598-020-58718-9</mixed-citation></ref><ref id="scirp.131269-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Callaghan, T.M. and Wilhelm, K.P. (2008) A Review of Ageing and an Examination of Clinical Methods in the Assessment of Ageing Skin. Part I: Cellular and Molecular Perspectives of Skin Ageing. International Journal of Cosmetic Science, 30, 313-322. https://doi.org/10.1111/j.1468-2494.2008.00454.x</mixed-citation></ref><ref id="scirp.131269-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Davinellia, S., Bertogliob, J.C., Polimenic, A. and Scapagninia, G. (2017) Cytoprotective Polyphenols against Chronological Skin Aging and Cutaneous Photodamage. Current Pharmaceutical Design, 24, 99-105.</mixed-citation></ref><ref id="scirp.131269-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Quan, T., Qin, Z., Xia, W., Shao, Y., Voorhees, J.J. and Fisher, G.J. (2009) Matrix-Degrading Metalloproteinases in Photoaging. Journal of Investigative Dermatology Symposium Proceedings, 14, 20-24. https://doi.org/10.1038/jidsymp.2009.8</mixed-citation></ref><ref id="scirp.131269-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Shin, J.W., Kwon, S.H., Choi, J.Y., Na, J.I., Huh, C.H., Choi, H.R. and Park, K.C. (2019) Molecular Mechanisms of Dermal Aging and Antiaging Approaches. International Journal of Molecular Sciences, 20, Article No. 2126. https://doi.org/10.3390/ijms20092126</mixed-citation></ref><ref id="scirp.131269-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Stern, R. and Maibach, H.I. (2008) Hyaluronan in Skin: Aspects of Aging and Its Pharmacologic Modulation. Clinics in Dermatology, 26, 106-122. https://doi.org/10.1016/j.clindermatol.2007.09.013</mixed-citation></ref><ref id="scirp.131269-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Papakonstantinou, E., Roth, M. and Karakiulakis, G. (2012) Hyaluronic Acid: A Key Molecule in Skin Aging. Dermato-Endocrinology, 4, 253-258. https://doi.org/10.4161/derm.21923</mixed-citation></ref><ref id="scirp.131269-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Chang, S.K., Alasalvar, C. and Shahidi, F. (2018) Superfruits: Phytochemicals, Antioxidant Efficacies, and Health Effects—A Comprehensive Review. Critical Reviews in Food Science and Nutrition, 23, 1-25.</mixed-citation></ref><ref id="scirp.131269-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Pullar, J.M., Carr, A.C. and Vissers, M. (2017) The Roles of Vitamin C in Skin Health. Nutrients, 9, Article No. 866. https://doi.org/10.3390/nu9080866</mixed-citation></ref><ref id="scirp.131269-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">Papaccio, F., D’Arino, A., Caputo, S. and Bellei, B. (2022) Focus on the Contribution of Oxidative Stress in Skin Aging. Antioxidants (Basel), 11, Article No. 1121. https://doi.org/10.3390/antiox11061121</mixed-citation></ref><ref id="scirp.131269-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">Chiba, H., Osanai, M., Murata, M., Kojima, T. and Sawada, N. (2008) Transmembrane Proteins of Tight Junctions. Biochimica et Biophysica Acta, 1778, 588-600. https://doi.org/10.1016/j.bbamem.2007.08.017</mixed-citation></ref><ref id="scirp.131269-ref23"><label>23</label><mixed-citation publication-type="other" xlink:type="simple">Jennemann, R., Rabionet, M., Gorgas, K., Epstein, S., Dalpke, A., Rothermel, U., Bayerle, A., Van der Hoeven, F., Imgrund, S., Kirsch, J., Nickel, W., Willecke, K., Riezman, H., Gr&amp;#246;ne, H.J. and Sandhoff, R. (2012) Loss of Ceramide Synthase 3 Causes Lethal Skin Barrier Disruption. Human Molecular Genetics, 21, 586-608. https://doi.org/10.1093/hmg/ddr494</mixed-citation></ref></ref-list></back></article>